Cash Flow ANI Pharmaceuticals, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
95.00
-22.00
19.00
-62.00
-56.00
-25.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-7.00
-11.00
24.00
-51.00
0.00
-12.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
185.00
64.00
118.00
-31.00
3.00
15.00
Cash Flow from Investing Activities
-34.00
-404.00
-18.00
-15.00
-105.00
-68.00
Cash Flow from Financing Activities
-9.00
264.00
67.00
-5.00
194.00
-1.00
Net Cash Inflow / Outflow
140.00
-76.00
167.00
-52.00
92.00
-54.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of ANI Pharmaceuticals, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
95.791
-89.633
184.00
206.87%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-7.123
47.452
-54.00
-115.01%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
185.225
-135.117
320.00
237.08%
Cash Flow from Investing Activities
-34.321
139.985
-173.00
-124.52%
Cash Flow from Financing Activities
-9.944
8.232
-17.00
-220.80%
Net Cash Inflow / Outflow
140.727
13.1
127.00
974.25%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.233
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 189.34% vs -46.19% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
185.22
64.02
189.34%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
